Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes: Orointestinale Sproßpilz‐Besiedlung bei pädiatrischen onkologischen Patienten unter Antimykotika‐Prophylaxe: quantitative kulturelle und Candida‐serologische Untersuchungen und Vergleich dreier Polyene

Mycoses

Volumn 38, Issue 1-2, 1995, Pages 41-49

  Hoppe, J E ^a   Friess, D ^b   Niethammer, D ^a  

^a University Children's Hospital ^*

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

amphotericin B; Candida; Candida serology; children; immunocompromised hosts; natamycin; nystatin; oncologic patients; polyenes; prophylaxis; yeast colonization

Indexed keywords

AMPHOTERICIN B; CHLORHEXIDINE; COLISTIN; COTRIMOXAZOLE; NATAMYCIN; NYSTATIN;

ADOLESCENT; ANTIFUNGAL ACTIVITY; ARTICLE; CANCER PATIENT; CANDIDA; CANDIDIASIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; CANDIDA; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOUTH; NATAMYCIN; NEOPLASMS; NYSTATIN;

CANDIDA;

EID: 0029009674     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1995.tb00007.x     Document Type: Article

References (52)

1. Infektionen unter immunsuppressiver Therapie im Kindesalter: Gefährdung und Übertragung‐swege
2. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy
3. Opportunistic fungal infections in patients with neoplastic disease
4. Fungal infections complicating acute leukemia
5. Fungemia in the immunocompromised host
6. Pilzinfektionen in der Onkologie
7. Fungal infections in patients with acute leukemia
8. The immune compromised host
9. Fungal infections of the immunocompromised host: clinical and laboratory aspects
10. Fungal infection and fever of unknown origin in neutropenc patients
11. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors
12. Fatal infections in childhood leukemia
13. Candida infections in children with neoplastic disease
14. Fatalities during remission of childhood leukemia
15. Mykologische Langzeituntersuchungen bei stationär betreuten Kindern mit Hämoblastosen und soliden Tumoren
16. Orointestinal yeast colonization of pacdiatric bone marrow transplant recipients: surveillance by quantitative culture and serology
17. Die Erregerdiagnostik der systemischen Pilzerkrankungen mit besonderer Berücksichtigung quantitativer Methoden
18. Die Serologie der Candida‐Infektionen
19. Vergleich von oraler Fluconazol‐ und Amphotericin‐B‐Prophylaxe gegen Pilzinfektionen in der Neutropenie‐Phase antileukämisch behandelter Patienten
20. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome
21. Infections in cancer patients
22. Hefebesiedlung der Schleimhäute und deren Kompli‐kationen unter zytostatischer Polychemotherapie
23. Carriage of Candida species and C. albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease
24. Risk factors for candidemia in patients with acute lymphocytic leukemia
25. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants
26. The value of fungal surveillance cultures as predictors of systemic fungal infections
27. Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia
28. Klinischer Verlauf und Risikofaktoren bei Patienten mit generalisierten Mykosen
29. Systemic candidiasis in cancer patients
30. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome
31. Candida colonization and systemic infection in neutropenic patients
32. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia
33. Chemoprophylaxis of fungal infections
34. Prospective study on humoral immune response induced by fungal infection in patients with haematologic malignancies
35. A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data
36. Candidosis: diagnostic tools in the laboratory
37. The value of serological methods in the diagnosis of Candida infections
38. Serodiagnosis of systemic candidiasis
39. Die Labordiagnostik der tieflokalisierten Candidose
40. Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications
41. Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemia
42. The effect of amphotericin B lozenges on the presence and number of Candida cells in the oropharynx of neutropenic leukemia patients
43. Polyene antibiotics in the prevention of Candida albicans colonization in the digestive tract of patients with severely decreased resistance to infection
44. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia
45. Treatment and prevention of oropharyngeal candidiasis
46. Bioassay for determination of nystatin in faeces after oral application
47. Concentrations of nystatin in faeces after oral administration of various doses of nystatin
48. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses